Letters, Testimony & Filings Letter to U.S. Congress Conference Committee for the Comprehensive Addiction and Recovery Act July 1, 2016
Letters, Testimony & Filings Testimony Before the FDA’s Drug Safety and Risk Management Committee and Anesthetic and Analgesic Drug Products Advisory Committee Regarding ALO-02 (Oxycodone/Naltrexone) June 8, 2016
Letters, Testimony & Filings Testimony Before the FDA’s Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee Regarding Opioid Analgesics May 4, 2016
Letters, Testimony & Filings Letters to CMS and the Joint Commission Requesting Roll Back of Pain Assessment Requirements That Foster Dangerous Overprescribing of Opioids April 13, 2016
Letters, Testimony & Filings Statement Before the Science Board to the Food and Drug Administration Regarding Opioid Drug Products March 1, 2016
Letters, Testimony & Filings Public Citizen, Partners Petition FDA for Black-Box Warnings on Opioids, Benzodiazepines About Dangers of Concurrent Use February 22, 2016
Letters, Testimony & Filings Comments on the CDC’s Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain January 13, 2016
Letters, Testimony & Filings Comments on the CDC’s Proposed 2016 Guideline for Prescribing Opioids for Chronic Pain January 13, 2016